COMPARABLE RISK OF RENAL DYSFUNCTION BETWEEN ENTECAVIR AND TENOFOVIR ALAFENAMIDE IN PATIENTS WITH CHRONIC HEPATITIS B

被引：0
|
作者：
Yang, Jiwon [1 ]
Lee, Yeojin [1 ]
Hong, Hyeyeon [1 ]
Chung, Sung Won [1 ]
Cho, Minjoo [1 ]
Choi, Won-Mook [2 ]
Lee, Danbi [1 ]
Shim, Ju Hyun [2 ]
Kim, Kang Mo [2 ]
Lim, Young-Suk [3 ]
Lee, Han Chu [1 ]
Choi, Jonggi [2 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Ctr Liver, Asan Med Ctr, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1407C
引用
收藏
页码：S510 / S510
页数：1
相关论文
共 50 条
  • [1] Comparable risk of cardiovascular events in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
    Hong, Hyeyeon
    Choi, Jonggi
    Choi, Won-Mook
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1139 - S1139
  • [2] Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
    Lee, Hye Won
    Cho, Young Youn
    Lee, Hyein
    Lee, Jae Seung
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Beom Kyung
    Park, Soo Young
    HEPATOLOGY INTERNATIONAL, 2021, 15 (05) : 1083 - 1092
  • [3] Higher risk of kidney function decline with entecavir than tenofovir alafenamide in patients with chronic hepatitis B
    Jung, Chan-Young
    Kim, Hyung Woo
    Ahn, Sang Hoon
    Kim, Seung Up
    Kim, Beom Seok
    LIVER INTERNATIONAL, 2022, 42 (05) : 1017 - 1026
  • [4] Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
    Hye Won Lee
    Young Youn Cho
    Hyein Lee
    Jae Seung Lee
    Seung Up Kim
    Jun Yong Park
    Do Young Kim
    Sang Hoon Ahn
    Beom Kyung Kim
    Soo Young Park
    Hepatology International, 2021, 15 : 1083 - 1092
  • [5] RENAL FUNCTION COMPARISON BETWEEN ENTECAVIR AND TENOFOVIR ALAFENAMIDE IN TREATMENTNA& IUML; VE CHRONIC HEPATITIS B
    Wang, Liang
    Ma, Shipeng
    Liu, Liping
    Wan, Xin
    Zhang, Yujing
    Ge, Shanfei
    HEPATOLOGY, 2024, 80 : S249 - S249
  • [6] Comparable efficacy with entecavir monotherapy and tenofovir-entecavir combination in chronic hepatitis B patients
    Baqai, Sumbella
    Proudfoot, James
    Xu, Ronghui
    Kane, Steve
    Clark, Margaret
    Gish, Robert
    BMJ OPEN GASTROENTEROLOGY, 2015, 2 (01):
  • [7] Switching from entecavir to tenofovir alafenamide versus maintaining entecavir for chronic hepatitis B
    Hagiwara, Satoru .
    Nishida, Naoshi
    Ida, Hiroshi
    Ueshima, Kazuomi
    Minami, Yasunori
    Takita, Masahiro
    Komeda, Yoriaki
    Kudo, Masatoshi
    JOURNAL OF MEDICAL VIROLOGY, 2019, 91 (10) : 1804 - 1810
  • [8] Low-level viremia in patients with chronic hepatitis B receiving entecavir, tenofovir and tenofovir alafenamide
    Wang, Xiaohao
    Cai, Dachuan
    Juan, Zhang
    JOURNAL OF HEPATOLOGY, 2022, 77 : S878 - S878
  • [9] Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients
    Sun, Yu-Tong
    Chen, Qian-Qian
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (01) : 109 - 111
  • [10] Effects of entecavir and tenofovir alafenamide fumarate treatment on renal function in Japanese elderly patients with chronic hepatitis B
    Tanaka, Misako
    Akahane, Takemi
    Kawaratani, Hideto
    Yorioka, Nobuyuki
    Koizumi, Aritoshi
    Asada, Shohei
    Matsuda, Takuya
    Iwai, Satoshi
    Tsuji, Yuki
    Fujinaga, Yukihisa
    Nishimura, Norihisa
    Kitagawa, Koh
    Kaji, Kosuke
    Namisaki, Tadashi
    Yoshiji, Hitoshi
    HEPATOLOGY RESEARCH, 2024, 54 (03) : 252 - 260
12345